First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in ...

Soliqua 100/33 (insulin glargine/lixisenatide ... You’ll use these pens to give yourself an injection of the drug under your skin. You’ll also have to get pen needles, which don’t come ...

Millender built off her own life experiences to co-found an institution that focuses on addressing the causes of health ...

any of the injection paradigms used would be acceptable and the technique should be based on patient preference. Possible concerns regarding smaller needles include greater insulin leakage or back ...

Needle-Free Injection Systems (N-FIS ... leading to higher compliance with treatments such as vaccinations and insulin therapy. Hospitals, clinics, and emergency departments often operate under ...

Treatment typically involves daily insulin injections or the use of an insulin pump to manage ... The insulin is injected through a needle. Some pens use cartridges inserted into the pen, while others ...

The company’s needle-free injection system uses a high-pressured, spring-driven stainless-steel piston, dispensing medication uniformly in a consistent, predictable, spray-like pattern. Upon injection ...

Preliminary studies suggest the capsule (the size of a blueberry) not only avoids the need for needle jabs but also ... in the UK with type 2 need insulin injections within six to ten years ...